87 related articles for article (PubMed ID: 34988768)
1. Contribution of cost to treatment nonadherence in the US breast cancer survivors: a population-based analysis.
Zheng C; Chagpar AB
Breast Cancer Res Treat; 2022 Apr; 192(2):369-373. PubMed ID: 34988768
[TBL] [Abstract][Full Text] [Related]
2. Cost-Related Medication Nonadherence in a Nationally Representative US Population with Self-Reported Glaucoma.
Gupta D; Ehrlich JR; Newman-Casey PA; Stagg B
Ophthalmol Glaucoma; 2021; 4(2):126-130. PubMed ID: 32841767
[TBL] [Abstract][Full Text] [Related]
3. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
[TBL] [Abstract][Full Text] [Related]
4. Recent Trends in Cost-Related Medication Nonadherence Among Cancer Survivors in the United States.
Lee MJ; Khan MM; Salloum RG
J Manag Care Spec Pharm; 2018 Jan; 24(1):56-64. PubMed ID: 29290172
[TBL] [Abstract][Full Text] [Related]
5. Association of Medication Nonadherence Among Adult Survivors of Stroke After Implementation of the US Affordable Care Act.
Levine DA; Burke JF; Shannon CF; Reale BK; Chen LM
JAMA Neurol; 2018 Dec; 75(12):1538-1541. PubMed ID: 30167647
[TBL] [Abstract][Full Text] [Related]
6. Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017.
Khera R; Valero-Elizondo J; Das SR; Virani SS; Kash BA; de Lemos JA; Krumholz HM; Nasir K
Circulation; 2019 Dec; 140(25):2067-2075. PubMed ID: 31760784
[TBL] [Abstract][Full Text] [Related]
7. Financial hardship among cancer survivors in Southern New Jersey.
Grafova IB; Manne SL; Bandera EV; Saraiya B; Llanos AAM; Devine KA; Hudson SV; Paddock LE; Tsui J; Elliott J; Stroup AM; Duberstein PR
Support Care Cancer; 2021 Nov; 29(11):6613-6623. PubMed ID: 33945015
[TBL] [Abstract][Full Text] [Related]
8. Is Yoga Associated With Improved Sleep Amongst Breast Cancer Survivors?
Jiwani S; Chagpar AB
Am Surg; 2022 Mar; 88(3):399-403. PubMed ID: 34983197
[TBL] [Abstract][Full Text] [Related]
9. Cost-Related Medication Nonadherence Among Older Adults: Findings From a Nationally Representative Sample.
Chung GC; Marottoli RA; Cooney LM; Rhee TG
J Am Geriatr Soc; 2019 Dec; 67(12):2463-2473. PubMed ID: 31437309
[TBL] [Abstract][Full Text] [Related]
10. Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors.
Yang J; Neugut AI; Wright JD; Accordino M; Hershman DL
J Oncol Pract; 2016 Aug; 12(8):e800-9. PubMed ID: 27407167
[TBL] [Abstract][Full Text] [Related]
11. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
Calip GS; Elmore JG; Boudreau DM
Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
[TBL] [Abstract][Full Text] [Related]
12. Health care access and utilization among adult cancer survivors: Results from the National Institutes of Health "All of Us" Research Program.
Coughlin SS; Chen J; Cortes JE
Cancer Med; 2021 Jun; 10(11):3646-3654. PubMed ID: 33942535
[TBL] [Abstract][Full Text] [Related]
13. Prescribing patterns in breast cancer survivors: A Korean National Health Insurance Service cohort study.
Oh HS; Chan A; Seo HJ
Int J Clin Pharmacol Ther; 2021 May; 59(5):358-365. PubMed ID: 33399068
[TBL] [Abstract][Full Text] [Related]
14. The effect of cost on adherence to prescription medications in Canada.
Law MR; Cheng L; Dhalla IA; Heard D; Morgan SG
CMAJ; 2012 Feb; 184(3):297-302. PubMed ID: 22249979
[TBL] [Abstract][Full Text] [Related]
15. Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act.
Nipp RD; Shui AM; Perez GK; Kirchhoff AC; Peppercorn JM; Moy B; Kuhlthau K; Park ER
JAMA Oncol; 2018 Jun; 4(6):791-797. PubMed ID: 29596618
[TBL] [Abstract][Full Text] [Related]
16. Does Cost-Related Medication Nonadherence among Cardiovascular Disease Patients Vary by Gender? Evidence from a Nationally Representative Sample.
Bhuyan SS; Shiyanbola O; Kedia S; Chandak A; Wang Y; Isehunwa OO; Anunobi N; Ebuenyi I; Deka P; Ahn S; Chang CF
Womens Health Issues; 2017; 27(1):108-115. PubMed ID: 27894670
[TBL] [Abstract][Full Text] [Related]
17. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
[TBL] [Abstract][Full Text] [Related]
18. Nonadherence to tamoxifen in breast cancer survivors: A 12 month longitudinal analysis.
Moon Z; Moss-Morris R; Hunter MS; Norton S; Hughes LD
Health Psychol; 2019 Oct; 38(10):888-899. PubMed ID: 31343218
[TBL] [Abstract][Full Text] [Related]
19. Drivers of cost differences between US breast cancer survivors with or without lymphedema.
Dean LT; Ransome Y; Frasso-Jaramillo L; Moss SL; Zhang Y; Ashing K; Denis GV; Frick KD; Visvanathan K; Schmitz KH
J Cancer Surviv; 2019 Oct; 13(5):804-814. PubMed ID: 31446591
[TBL] [Abstract][Full Text] [Related]
20. Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancer.
Bradley CJ; Dahman B; Jagsi R; Katz S; Hawley S
Breast Cancer Res Treat; 2015 Nov; 154(2):417-22. PubMed ID: 26553168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
